KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gsk (GSK) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $3.7 billion.

  • Gsk's Consolidated Net Income rose 446187.52% to $3.7 billion in Q3 2025 from the same period last year, while for Dec 2025 it was $9.7 billion, marking a year-over-year increase of 1210.01%. This contributed to the annual value of $13.2 billion for FY2022, which is 50915.79% up from last year.
  • Latest data reveals that Gsk reported Consolidated Net Income of $3.7 billion as of Q3 2025, which was up 446187.52% from $2.8 billion recorded in Q2 2025.
  • Gsk's 5-year Consolidated Net Income high stood at $11.9 billion for Q3 2022, and its period low was $81.9 million during Q3 2024.
  • For the 5-year period, Gsk's Consolidated Net Income averaged around $2.5 billion, with its median value being $2.1 billion (2024).
  • Per our database at Business Quant, Gsk's Consolidated Net Income tumbled by 9684.46% in 2024 and then skyrocketed by 446187.52% in 2025.
  • Quarter analysis of 5 years shows Gsk's Consolidated Net Income stood at $687.5 million in 2021, then grew by 6.63% to $733.1 million in 2022, then surged by 687.27% to $5.8 billion in 2023, then decreased by 24.92% to $4.3 billion in 2024, then decreased by 13.82% to $3.7 billion in 2025.
  • Its Consolidated Net Income was $3.7 billion in Q3 2025, compared to $2.8 billion in Q2 2025 and $3.1 billion in Q1 2025.